Skip to main content
. 2023 Feb 8;41(2):107–121. [Article in Chinese] doi: 10.3724/SP.J.1123.2022.07020

表2.

不同分析方法获得的肝素或低分子量肝素的二糖组成

No. Composition SAX-
UVHep[63]
SAX-
SECHep[65]
SAX-
SECEno[66]
SAX-
SECNadro[66]
IPRP-
MSEno[70]
HILIC-
MSNadro[72]
HILIC-
MSEno[60]
1 ΔU-GlcNAc 1 1 1 1 1 1 1
2 ΔU-GlcNS 1 1 1 1 1 1 1
3 ΔU-GlcNAc,6S 1 1 1 1 1 1 1
4 ΔU2S-GlcNAc 1 1 1 1 1 1 1
5 ΔU-GlcNS,6S 1 1 1 1 1 1 1
6 ΔU2S-GlcNS 1 1 1 1 1 1 1
7 ΔU2S-GlcNAc,6S 1 1 1 1 1 1 1
8 ΔU2S-GlcNS,6S 1 1 1 1 1 1 1
9 ΔGalA-GlcNS 1 0 0 0 0 1 1
10 ΔGalA-GlcNS,6S 1 0 0 0 0 1 1
12 IdoA2S-GlcNS 1 0 0 0 0 1 1
13 U2S-GlcNS or U-GlcNS,6S 0 0 1 0 0 0 0
14 U2S-GlcNAc or U-GlcNAc,6S 0 0 0 1 0 0 0
15 IdoA2S-GlcNS,6S 1 0 0 0 0 1 1
16 ΔU2S-GlcN,6S 0 0 0 0 0 1 1
17 ΔU2S-GlcN 0 0 0 0 0 1 1
18 ΔU-GlcN,6S 0 0 0 0 0 1 1
19 ΔU-GlcN 0 0 0 0 0 0 1
20 ΔGlyser 1 1 1 1 0 1 1
No. Composition SAX-
UVHep[63]
SAX-
SECHep[65]
SAX-
SECEno[66]
SAX-
SECNadro[66]
IPRP-
MSEno[70]
HILIC-
MSNadro[72]
HILIC-
MSEno[60]
21 ΔGlyserox1 1 0 0 0 0 1 1
22 ΔGlyserox2 1 0 0 0 0 0 0
23 Other non-endogenous derivatives ΔISO3 1 0 0 0 0 0 0
24 Tetrasaccharide A ΔIS-I2SO3 1 0 0 0 0 0 0
25 Tetrasaccharide B ΔI2SO3-Isid 1 0 0 0 0 0 0
26 ΔU-GlcNAc,6S-GlcA-GlcNS,3S 1 0 0 0 0 0 0
27 ΔU-GlcNAc,6S-GlcA-GlcNS,3S,6S 1 1 1 1 1 1 1
28 ΔU-GlcNS,6S-GlcA-GlcNS,3S,6S 1 1 1 0 0 1 1
29 ΔU2S-GlcNAc,6S-GlcA-GlcNS,3S,6S 1 0 0 0 0 1 0
30 ΔU2S-GlcNS,6S-GlcA-GlcNS,3S,6S 1 0 0 0 0 1 0
31 GlcNS-IdoA2S-GlcNS,6S or GlcNS, 0 0 1 0 0 0 0
6S-IdoA2S-GlcNS
32 GlcNS,6S-IdoA2S-GlcNS,6S 1 0 0 0 0 1 1
33 ΔU-GlcNS,6S-HexA 0 0 0 0 0 1 1
34 ΔU2S-GlcNAc,6S-HexA 0 0 0 0 0 0 1
35 ΔU2S-GlcNS,6S-HexA 0 0 0 0 0 1 1
36 ΔU2S-GlcNS,6S-HexA2S 0 0 1 0 0 1 1
37 ΔU2CS-GlcNS,6S 0 0 0 0 0 1 1
38 GlcNS,6S-U2CS-GlcNS or GlcNS-U2CS-GlcNS,6S 0 0 0 1 0 0 0
39 ΔUA2S-GlcNS,6S-GlcA-2,3-anhydro-GlcNS 0 0 0 0 0 1 1
40 ΔUA-GlcNS-HexA2S,3S-GlcNS 0 0 0 0 0 1 1
41 3-O-S Δdp2 0 0 0 0 0 1 0
42 3-O-S Δdp4(3S,1Ac) 0 0 0 0 0 1 0
43 3-O-S Δdp4(4S,0Ac) 0 1 1 0 0 1 0
44 3-O-S Δdp4(4S,1Ac) 0 2 0 0 0 0 0
45 3-O-S Δdp4(5S,0Ac) 0 3 0 0 0 0 0
46 ΔU- Mnt6S 0 0 0 1 0 1 0
47 ΔU2S- Mnt6S 0 0 0 1 0 1 0
48 GlcNS,6S-U2S-Mnt6S 0 0 0 1 0 0 0
49 ΔU2S-GlcNS-U-Mnt6S 0 0 0 0 0 1 0
50 ΔU2S-GlcNAc-U2S-Mnt6S 0 0 0 1 0 0 0
51 ΔU2S-GlcNS-U2S-Mnt6S 0 0 0 1 0 1 0
52 ΔU2S-GlcNS,6S-U2S-Mnt6S 0 0 0 1 0 1 0
53 MntΔdp5(5S,1Ac) 0 0 0 1 0 0 0
54 MntΔdp6(6S,1Ac) 0 0 0 1 0 0 0
55 ΔU-1,6-anhydroGlcNS 0 0 0 0 0 0 1
56 ΔU-1,6-anhydroManNS 0 0 0 0 0 0 1
57 ΔU2S-1,6-anhydroHexNS 0 0 0 0 2 0 1
58 GlcNS,6S-U2S-1,6-anhydroHexNS 0 0 1 0 0 0 0
59 ΔU2S-GlcNS,6S-U2S-1,6-anhydroManNS 0 0 0 0 1 0 1

Hep:heparin sodium;Eno:enoxaparin sodium;Nadro:nadroparin calcium;Mnt:2,5-AM. ol;SEC:size-exclusion chromatography;HILIC:hydrophilic interaction chromatography;ΔU2S-GlcNAc,6S:unsaturated disaccharide with 2-O-sulfated uronic acid and N-acetylated,6-O-sulfated glucosamine;3-O-S Δdp4(3S,1Ac):unsaturated tetrasaccharide with 3-O-sulfated glucosamine(total three sulfo groups,one acetyl group);1:detected;0:no detected.